Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was up 18.4% during trading on Tuesday . The stock traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 4,184,618 shares were traded during mid-day trading, an increase of 135% from the average daily volume of 1,782,671 shares. The stock had previously closed at GBX 1.60 ($0.02).
Cizzle Biotechnology Stock Down 1.5 %
The stock has a 50-day moving average of GBX 1.79 and a 200 day moving average of GBX 1.85. The stock has a market cap of £7.61 million, a PE ratio of -192.00 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- Are Penny Stocks a Good Fit for Your Portfolio?
- Breaking the Mold: 3 Non-Tech Stocks Ready to Surge in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Your Best Trading Year Starts Here: Top 3 Stocks for 2025 Gains
- How Can Investors Benefit From After-Hours Trading
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
